Table 4.

Characteristics associated with risk of nonhumoral response to a third dose of mRNA COVID-19 vaccine after multivariate analysis (n = 129)

Characteristics	OR	95% CI	P value
Male recipient	0.25	0.10–0.61	0.0027
Allograft function by MDRD, ml/min	0.97	0.94–0.99	0.0232
Antimetabolite treatment	1.76	0.59–5.64	0.3237
Steroid treatment	2.45	0.91–6.81	0.0795
Lymphocytes <1500/mm3	3.84	1.58–9.96	0.0039

CI, confidence interval; COVID-19, coronavirus disease 2019; MDRD, Modification of Diet in Renal Disease; OR, odds ratio.

Values in bold are significant (P < 0.05).